These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7849969)

  • 1. Use of current generation perfluorocarbon emulsions in cardiac surgery.
    Holman WL; McGiffin DC; Vicente WV; Spruell RD; Pacifico AD
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):979-90. PubMed ID: 7849969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perfluorocarbons are effective oxygen carriers in cardiopulmonary bypass.
    Spruell RD; Ferguson ER; Clymer JJ; Vicente WV; Murrah CP; Holman WL
    ASAIO J; 1995; 41(3):M636-41. PubMed ID: 8573883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of exchange transfusion with a red blood cell substitute on the neonatal lung.
    Breuninger HG; Wolfson MR; Rubenstein SD; Shaffer TH
    J Dev Physiol; 1990 Nov; 14(5):283-9. PubMed ID: 2100743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perfluorocarbon-based oxygen delivery.
    Riess JG
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):567-80. PubMed ID: 17090429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perfluorocarbon-based oxygen carriers: review of products and trials.
    Castro CI; Briceno JC
    Artif Organs; 2010 Aug; 34(8):622-34. PubMed ID: 20698841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood substitutes. Artificial oxygen carriers: perfluorocarbon emulsions.
    Spahn DR
    Crit Care; 1999; 3(5):R93-7. PubMed ID: 11094488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perfluorocarbon emulsions and cardiopulmonary bypass: a technique for the future.
    Spiess BD; Cochran RP
    J Cardiothorac Vasc Anesth; 1996 Jan; 10(1):83-89; quiz 89-90. PubMed ID: 8634391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fluorocarbons: applications to cardiovascular surgery (author's transl)].
    Menasché P; Piwnica A
    Nouv Presse Med; 1982 Jun; 11(30):2289-92. PubMed ID: 7110991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A second-generation blood substitute (perfluorodichlorooctane emulsion) does not activate complement during an ex vivo circulation model of bypass.
    Rosoff JD; Soltow LO; Vocelka CR; Schmer G; Chandler WL; Cochran RP; Kunzelman KS; Spiess BD
    J Cardiothorac Vasc Anesth; 1998 Aug; 12(4):397-401. PubMed ID: 9713726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perfluorocarbon oxygen transport. A comparative study of four oxygenator designs.
    Ferguson ER; Clymer JJ; Spruell RD; Holman WL
    ASAIO J; 1994; 40(3):M649-53. PubMed ID: 8555594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxygen solubility, rheology and hemodynamics of perfluorocarbon emulsion blood substitutes.
    Millard RW
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(2):235-44. PubMed ID: 8087245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of perfluorochemicals during open heart surgery.
    Kanter KR; Gardner TJ
    Int Anesthesiol Clin; 1985; 23(1):105-14. PubMed ID: 3980101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perfluorocarbons in the twenty-first century: clinical applications as transfusion alternatives.
    Spence RK
    Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(3):367-80. PubMed ID: 7493058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in air bubble size using perfluorocarbons during cardiopulmonary bypass in the rat.
    Yoshitani K; de Lange F; Ma Q; Grocott HP; Mackensen GB
    Anesth Analg; 2006 Nov; 103(5):1089-93. PubMed ID: 17056937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfluorinated blood substitutes and artificial oxygen carriers.
    Lowe KC
    Blood Rev; 1999 Sep; 13(3):171-84. PubMed ID: 10527269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood substitutes and oxygen therapeutics: an overview and current status.
    Jahr JS; Nesargi SB; Lewis K; Johnson C
    Am J Ther; 2002; 9(5):437-43. PubMed ID: 12237737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perfluorocarbon administration during cardiopulmonary bypass in rats: an inflammatory link to adverse outcome?
    de Lange F; Yoshitani K; Proia AD; Mackensen GB; Grocott HP
    Anesth Analg; 2008 Jan; 106(1):24-31, table of contents. PubMed ID: 18165547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased antioxidant capacity, suppression of free radical damage and erythrocyte aggrerability after combined application of alpha-tocopherol and FC-43 perfluorocarbon emulsion in early postburn period in rats.
    Bekyarova G; Yankova T; Galunska B
    Artif Cells Blood Substit Immobil Biotechnol; 1996 Nov; 24(6):629-41. PubMed ID: 8922232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perfluorocarbons as oxygen-transport fluids.
    Lowe KC
    Comp Biochem Physiol A Comp Physiol; 1987; 87(4):825-38. PubMed ID: 2887381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oxygen carriers in cardiac surgery].
    Molina Méndez FJ
    Arch Cardiol Mex; 2006; 76 Suppl 2():S100-6. PubMed ID: 17017083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.